These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 6087460)

  • 21. Association of liver tumors with oral contraceptives.
    Nissen ED; Kent DR; Nissen SE; McRae DM
    Obstet Gynecol; 1976 Jul; 48(1):49-55. PubMed ID: 180466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal nodular hyperplasia and adenoma of the liver. A pediatric experience.
    Dehner LP; Parker ME; Franciosi RA; Drake RM
    Am J Pediatr Hematol Oncol; 1979; 1(1):85-93. PubMed ID: 232373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of steroids to liver oncogenesis.
    Christopherson WM; Mays ET
    J Toxicol Environ Health; 1979; 5(2-3):207-30. PubMed ID: 224196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of hepatocellular adenoma and focal nodular hyperplasia of the liver in a woman on oral contraceptives].
    Defrance R; Zafrani ES; Hannoun S; Saada M; Fagniez PL; Métreau JM
    Gastroenterol Clin Biol; 1982 Nov; 6(11):949-50. PubMed ID: 6295869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary malignant tumour of the liver associated with the ingestion of oral contraceptives (author's transl)].
    Leclere J; Meot B; Marchal F; Mizrahi R; Collard F; Begue JY; Rauber G; Hartemann P
    Nouv Presse Med; 1979 Jan; 8(5):346-9. PubMed ID: 233379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos.
    Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A
    Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic adenoma and oral contraceptives: personal case].
    Cassinelli GB
    Ann Ital Chir; 1985; 57(2):101-7. PubMed ID: 3004281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver oncogenesis and steroids.
    Christopherson WM; Mays ET; Barrows GH
    Prog Clin Cancer; 1978; 7():153-63. PubMed ID: 212780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Contraception and hepatogastroenterology].
    Grimaud JC; Bourliere M
    Fertil Contracept Sex; 1989 May; 17(5):407-13. PubMed ID: 12316076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral contraceptives and hepatic tumors.
    Wilson JH
    Agressologie; 1982 Jan; 23(A):21-3. PubMed ID: 7081579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case control study finds long-term pill use is associated with higher risk of benign liver tumors.
    Int Fam Plann Dig; 1976 Jun; 2(2):13-5. PubMed ID: 12334249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.
    Tesluk H; Lawrie J
    Arch Pathol Lab Med; 1981 Jun; 105(6):296-9. PubMed ID: 6263214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.
    Reddy KR; Kligerman S; Levi J; Livingstone A; Molina E; Franceschi D; Badalamenti S; Jeffers L; Tzakis A; Schiff ER
    Am Surg; 2001 Feb; 67(2):173-8. PubMed ID: 11243545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Budd-Chiari syndrome and hepatic adenomas associated with oral contraceptives. A case report.
    Tong HK; Fai GL; Ann LT; Hock OB
    Singapore Med J; 1981 Jun; 22(3):168-72. PubMed ID: 6272427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic complications of oral contraceptives].
    Saint-marc Girardin MF
    Contracept Fertil Sex (Paris); 1984 Jan; 12(1):13-6. PubMed ID: 12312749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rupture and hemorrhage of hepatic focal nodular hyperplasia.
    Becker YT; Raiford DS; Webb L; Wright JK; Chapman WC; Pinson CW
    Am Surg; 1995 Mar; 61(3):210-4. PubMed ID: 7887531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.